ReviewJournal of gastrointestinal cancer2026

Positioning Zolbetuximab in HER2-Negative Advanced Gastric Cancer: A Practical Framework for Treatment Selection in the ICI Era.

Tamotsu Sagawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.